Huizing MT - Search Results

1

Taxanes: a new class of antitumor agents.

Huizing MT, Misser VH, Pieters RC, ten Bokkel Huinink WW, Veenhof CH, Vermorken JB, Pinedo HM, Beijnen JH. Huizing MT, et al. Cancer Invest. 1995;13(4):381-404. doi: 10.3109/07357909509031919. Cancer Invest. 1995. PMID: 7627725 Review.

2

Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer.

Giaccone G, Huizing M, Postmus PE, ten Bokkel Huinink WW, Koolen M, van Zandwijk N, Vermorken JB, Beijnen JH, Dalesio O, Pinedo HM, et al. Giaccone G, et al. Semin Oncol. 1995 Aug;22(4 Suppl 9):78-82. Semin Oncol. 1995. PMID: 7544030 Clinical Trial.

3

Carboplatin and paclitaxel in patients with advanced ovarian cancer: a dose-finding study.

ten Bokkel Huinink W, Veenhof C, Huizing M, Rodenhuis S, Helmerhorst T, Dubbelman R, Dalesio O, Beijnen J, Winograd B. ten Bokkel Huinink W, et al. Semin Oncol. 1997 Feb;24(1 Suppl 2):S2-31-S2-33. Semin Oncol. 1997. PMID: 9045333 Clinical Trial.

4

High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial.

Vermorken JB, ten Bokkel Huinink WW, Mandjes IA, Postma TJ, Huizing MT, Heimans JJ, Beijnen JH, Bierhorst F, Winograd B, Pinedo HM. Vermorken JB, et al. Among authors: huizing mt. Semin Oncol. 1995 Aug;22(4 Suppl 8):16-22. Semin Oncol. 1995. PMID: 7543699 Clinical Trial.

5

Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces.

Sparreboom A, Huizing MT, Boesen JJ, Nooijen WJ, van Tellingen O, Beijnen JH. Sparreboom A, et al. Among authors: huizing mt. Cancer Chemother Pharmacol. 1995;36(4):299-304. doi: 10.1007/BF00689047. Cancer Chemother Pharmacol. 1995. PMID: 7628049

6

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.

Huizing MT, Keung AC, Rosing H, van der Kuij V, ten Bokkel Huinink WW, Mandjes IM, Dubbelman AC, Pinedo HM, Beijnen JH. Huizing MT, et al. J Clin Oncol. 1993 Nov;11(11):2127-35. doi: 10.1200/JCO.1993.11.11.2127. J Clin Oncol. 1993. PMID: 7901342 Clinical Trial.

7

Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol).

Beijnen JH, Huizing MT, ten Bokkel Huinink WW, Veenhof CH, Vermorken JB, Giaccone G, Pinedo HM. Beijnen JH, et al. Among authors: huizing mt. Semin Oncol. 1994 Oct;21(5 Suppl 8):53-62. Semin Oncol. 1994. PMID: 7939764 Review.

8

Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.

Huizing MT, Vermorken JB, Rosing H, ten Bokkel Huinink WW, Mandjes I, Pinedo HM, Beijnen JH. Huizing MT, et al. Ann Oncol. 1995 Sep;6(7):699-704. doi: 10.1093/oxfordjournals.annonc.a059287. Ann Oncol. 1995. PMID: 8664192 Free article. Clinical Trial.

9

Isolation, purification and biological activity of major docetaxel metabolites from human feces.

Sparreboom A, Van Tellingen O, Scherrenburg EJ, Boesen JJ, Huizing MT, Nooijen WJ, Versluis C, Beijnen JH. Sparreboom A, et al. Among authors: huizing mt. Drug Metab Dispos. 1996 Jun;24(6):655-8. Drug Metab Dispos. 1996. PMID: 8781781

10

Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography.

Huizing MT, Sparreboom A, Rosing H, van Tellingen O, Pinedo HM, Beijnen JH. Huizing MT, et al. J Chromatogr B Biomed Appl. 1995 Dec 15;674(2):261-8. doi: 10.1016/0378-4347(95)00308-8. J Chromatogr B Biomed Appl. 1995. PMID: 8788155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page